Toxic Anterior Segment Syndrome After ICL Implantation: Keratoconus & Nystagmus Case Report
Rare Complication Following Implantable Collamer lens (ICL) Surgery: A Case Study
Table of Contents
Published November 9, 2025
Understanding Toxic Anterior Segment Syndrome (TASS)
A recent case report details a rare but serious complication-Toxic Anterior Segment Syndrome (TASS)-that arose following Implantation of an Implantable Collamer Lens (ICL) in a patient with pre-existing keratoconus and nystagmus. TASS is a non-infectious inflammatory reaction within the eye, occurring typically within 12-48 hours after surgery. It’s characterized by significant anterior chamber inflammation, corneal edema, and a decrease in visual acuity.
Patient Profile and Surgical Details
The reported case involved a patient presenting with both keratoconus (a progressive thinning of the cornea) and nystagmus (involuntary eye movements).ICL surgery was undertaken to correct the patient’s refractive error. The ICL is a phakic intraocular lens, meaning it’s implanted without removing the natural lens of the eye, offering a refractive solution for high myopia or astigmatism.
Post-Operative Complications and Diagnosis
Within 24 hours of the ICL implantation, the patient exhibited signs consistent with TASS, including pronounced inflammation in the anterior chamber of the eye. The inflammation was severe enough to cause a significant reduction in vision. Diagnostic evaluation ruled out infectious causes, leading to a diagnosis of TASS.
Potential Causes and Management
While the exact cause of TASS remains unclear, it is often linked to substances released from surgical instruments or the implanted lens itself. In this case, the patient’s pre-existing corneal irregularities from keratoconus and the presence of nystagmus may have contributed to the severity of the reaction. Management of TASS typically involves aggressive topical steroid treatment to reduce inflammation and manage symptoms. The case report highlights the importance of careful patient selection and meticulous surgical technique when performing ICL surgery, notably in individuals with corneal abnormalities or ocular motility disorders.
Implications for ICL Surgery
This case underscores the need for ophthalmologists to be aware of the potential for TASS, even in carefully screened patients. Prompt recognition and treatment are crucial to minimizing long-term visual impairment. Further research is needed to identify the specific factors that contribute to TASS and to develop strategies for prevention.